The effect of Wegovy 2.4 mg once weekly on the risk of major cardiovascular events such as death, heart attack, or stroke was studied in adults with known heart disease and either obesity or overweight compared with those on placebo (an inactive injection)
Studies are also underway for a spectrum of other conditions, including Phase 3 trials investigating non-alcoholic steatohepatitis (NASH), chronic kidney disease (CKD), and obstructive sleep apnea (OSA), as well as mid-to-late stage trials exploring potential benefits in neurodegenerative disorders like Parkinsons disease
J., Sundberg J
Other diabetes drugs used for blood sugar control, such as Jardiance Other weight loss medications Medicines for high blood pressure Your online doctor will order labs for you before prescribing GLP-1 medications
At Set Point Medical Weight Loss Clinic, we can help you understand the potential benefits and drawbacks of GLP-1 agonists and other weight management strategies
doi:10.1006/jmbi.1998.1927